Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Chi Leung Chiang"'
Autor:
Shing Fung Lee, Horace C. W. Choi, Sik Kwan Chan, Ka On Lam, Victor H. F. Lee, Irene O. L. Wong, Chi Leung Chiang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivesWe aimed to compare the economic value of chemotherapy plus anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibody (mAb) against chemotherapy with bevacizumab (Bev, an anti-vascular endothelial growth factor mAb) as first-lin
Externí odkaz:
https://doaj.org/article/111ed691c06345b4aa7a33edb674f9fd
Autor:
S Y Yeung, Ka-On Lam, K S Lau, H C Choi, S F Lee, K K Yuen, Siok-Yee Chan, Chi-Leung Chiang, B Y Chan, TS Choy
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 15:5-13
AIM To investigate treatment patterns and outcomes of metastatic colorectal cancer (mCRC) patients beyond second progression (PD2) since regorafenib and TAS-102 became available in Hong Kong. METHODS The clinical records of consecutive mCRC patients
Publikováno v:
Hong Kong Journal of Radiology. :312-317
Autor:
Horace Cheuk-Wai Choi, S. Lee, Ka-On Lam, Chi-Leung Chiang, Sum-Yin Chan, Ian C. K. Wong, Victor C. S. Lee
Publikováno v:
Annals of Oncology. 31:S135
Autor:
K. Lau, Albert C. Y. Chan, Tan To Cheung, Chi-Leung Chiang, W. She, K. Ma, Tze Wai Wong, Ka-On Lam, W. Chan, Kenneth S. H. Chok, Matthew T. V. Chan, W. Dai, J. Ko, T-C. Lam, Tsz-Him So, K. Chu, S. Wu, M. Lung, Horace C.W. Choi, V. Wong, Victor C. S. Lee, C. Lam
Publikováno v:
Annals of Oncology. 30:iv115-iv116
Publikováno v:
Molecular and Clinical Oncology. 3:1398-1400
Capecitabine is a commonly used anticancer drug, which has been associated with adverse events, including skin and gastrointestinal symptoms, such as vomiting and diarrhea. We herein present treated two rare cases of capecitabine-associated ileitis.
Autor:
Francis A. S. Lee, Chi-Leung Chiang, Chi Ming Poon, Stewart Y. Tung, Frank Chi Sing Wong, Yiu Wah Wong, Shing Fung Lee
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 9, Pp 825-832 (2018)
Background: For advanced rectal cancer with involved or threatened mesorectal fascia (MRF), current standard is pre-operative long course chemoradiotherapy (PLCRT) with either capecitabine or 5-fluorouracil (5-FU). However, few Chinese data on its cl
Publikováno v:
Annals of Oncology. 30:iv58
Autor:
SHING FUNG LEE1, CHI LEUNG CHIANG1, SHING LEE, ANN1, CHI SHING WONG, FRANK1, YUK TUNG, STEWART1
Publikováno v:
Molecular & Clinical Oncology. Nov/Dec2015, Vol. 3 Issue 6, p1398-1400. 3p.
Publikováno v:
Radiotherapy and Oncology. 123:S678-S679